MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-28-0078035
Meritor Pharmaceutical Private Limited - pharma in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.22 Cr
▲ 41% YoY
Net profit · FY 2025
₹21.14 Lakh
Net margin 4.1%
EBITDA · FY 2025
₹21.6 Lakh
EBITDA margin 4.1%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹12.85 Lakh
Issued & subscribed
Satisfied charges
₹50 Lakh
No open charges
Company age
12 yrs
Est. 2014
Employees · EPFO
14
Provident fund records
About Meritor Pharmaceutical Private Limited
Data last updated:
Meritor Pharmaceutical Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24233UP2014PTC067191. Its GSTIN is 09AAJCM4948H1Z0 (Uttar Pradesh).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹12.85 Lakh. It is led by directors including Dhruvendra Kishor Singh and Muresh Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 69 Ground Floor Sector 65, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.22 Cr, a growth of 41% compared to the previous year. For the same year it recorded a net profit of ₹21.14 Lakh (net margin 4.1%) and EBITDA of ₹21.6 Lakh (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 5% over five years.
The company has about 14 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹50 Lakh on record.
Meritor Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0078035). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website meritorpharmaceutical.com.
Company details
CIN U24233UP2014PTC067191
Registration Number 067191
Incorporation Date 21 November 2014
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0078035
Recognitions & Rankings of Meritor Pharmaceutical
Contact details
Meritor Pharmaceutical Private Limited's registered office is in Noida, Uttar Pradesh. Its website is meritorpharmaceutical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 69 Ground Floor Sector 65, Noida, Uttar Pradesh, India – 201301
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Meritor Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Meritor Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Meritor Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Meritor Pharmaceutical Private Limited, buy the company report.
Financials of Meritor Pharmaceutical Private Limited
FY 2025 filings availableMeritor Pharmaceutical Private Limited reported revenue of ₹5.22 Cr (up 41% YoY) for FY 2025.
Revenue · FY 2025
₹5.22 Cr ▲ 41%
Net profit · FY 2025
₹21.14 Lakh margin 4.1%
EBITDA · FY 2025
₹21.6 Lakh margin 4.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 41%
3 years · compounded
▲ 19%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 540%
3 years · compounded
▼ 6%
5 years · compounded
▲ 21%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 41% growth in the latest year. EBITDA rose 540% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | 4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Meritor Pharmaceutical Private Limited, buy the company report.
Board of directors of Meritor Pharmaceutical Private Limited
Meritor Pharmaceutical has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhruvendra Kishor Singh | Director | 21 Nov 2014 | 11 Years 11 Months | Current |
| Muresh Yadav | Director | 21 Nov 2014 | 11 Years 11 Months | Current |
| Sandeep Kumar Srivastava | Director | 10 Dec 2014 | 11 Years 10 Months | Current |
| Durgeshwar Srivastava | Director | 21 Nov 2014 | 11 Years 11 Months | Current |
Peer comparison
Meritor Pharmaceutical Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alpha Plus Medicos Private Limited | ₹5.24 Cr (FY 2023) | 33.0% | Delhi, India | |||
| Truemed Chemist and Druggist Private Limited | ₹5.24 Cr (FY 2025) | -8.0% | Lucknow, Uttar Pradesh, India | |||
| Meritor Pharmaceutical Private Limitedthis company | ₹5.22 Cr (FY 2025) | ₹21.14 Lakh | 4.1% | 41.0% | Noida, Uttar Pradesh, India | |
| Shree Ranisati Distributors Private Limited | ₹5.22 Cr (FY 2025) | 14.0% | Lucknow, Uttar Pradesh, India | |||
| Naticon Research Labs Private Limited | ₹5.2 Cr (FY 2025) | -8.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of Meritor Pharmaceutical Private Limited, buy the company report.
Auditor
Meritor Pharmaceutical Private Limited is audited by MANISH RATNESH & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANISH RATNESH & ASSOCIATES | FY 2017 | 015734C |
Shareholding
The shareholding of Meritor Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Meritor Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹50 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Aug 2015 | 10594828 | Allahabad Bank | ₹50 Lakh | Satisfied |
To see the full charge records of Meritor Pharmaceutical Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Meritor Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meritor Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Meritor Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAJCM4948H1Z0 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Meritor Pharmaceutical Private Limited, buy the company report.
Recent activity
Meritor Pharmaceutical Private Limited has 5 board changes on record since 2014: 4 appointments and 1 cessation. The latest: Alka Singh ceased to be Director on 01 Aug 2025.
AGM
Meritor Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Alka Singh ceased to be Director.
Filing
Meritor Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Charges
A charge registered on 18 Aug 2015 via Charge ID 10594828 with Allahabad Bank was fully satisfied on 11 Jul 2019.
Charges
A charge with Allahabad Bank amounted to Rs. 50.00 Lakh with Charge ID 10594828 was registered on 18 Aug 2015.
Appointed
Sandeep Kumar Srivastava was appointed as Director.
Appointed
Dhruvendra Kishor Singh was appointed as Director.
Appointed
Durgeshwar Srivastava was appointed as Director.
Appointed
Muresh Yadav was appointed as Director.
Incorporation
21 Nov 2014
Meritor Pharmaceutical Private Limited was registered on 21 Nov 2014 with Roc Uttar Pradesh Ii & aged 11 years 11 months as per MCA records.
Frequently asked questions
Meritor Pharmaceutical is an active private limited company based in Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 November 2014 (12+ years old) and is registered under CIN U24233UP2014PTC067191.
Meritor Pharmaceutical has 4 current directors:
- Dhruvendra Kishor Singh - Director
- Muresh Yadav - Director
- Sandeep Kumar Srivastava - Director
- Durgeshwar Srivastava - Director
The latest financial statements of Meritor Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Meritor Pharmaceutical is 09AAJCM4948H1Z0, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Meritor Pharmaceutical is U24233UP2014PTC067191. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meritor Pharmaceutical was incorporated on 21 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Meritor Pharmaceutical by revenue are Alpha Plus Medicos Private Limited, Truemed Chemist and Druggist Private Limited, Shree Ranisati Distributors Private Limited, Naticon Research Labs Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Alka Singh ceased to be Director on 01 Aug 2025. Sandeep Kumar Srivastava was appointed as Director on 10 Dec 2014. Dhruvendra Kishor Singh was appointed as Director on 21 Nov 2014. Meritor Pharmaceutical has 5 board changes on record in total.
Yes, Meritor Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0078035).
Meritor Pharmaceutical can be reached through the website meritorpharmaceutical.com. Its registered office is in Noida, Uttar Pradesh, India.
The registered office of Meritor Pharmaceutical is at A – 69 Ground Floor Sector 65, Noida, Uttar Pradesh, India – 201301.